Screening EGFR Mutations in Lung Cancer

Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLCПодробнее

Health Equity Across the Cancer Care Continuum: Lung CancerПодробнее

Dr. Natasha Leighl Explains the Impact of EGFR Mutations on Lung Cancer Treatment #EGFR #BiomarkerПодробнее

Targeted therapy in Lung Cancer : A prototype for precision medicineПодробнее

CRSF 07th Masterclass: Uncommon EGFR Mutations in Lung Cancer | Dr. Pradeep VentrapatiПодробнее

Newer Updates on Lung Cancer Treatment Updates 2024Подробнее

How do doctors treat lung cancer with EGFR mutations?Подробнее

What is an EGFR mutation in lung cancer?Подробнее

What is an ALK rearrangement in lung cancer?Подробнее

Understanding NSCLC Treatment When You Have an EGFR MutationПодробнее

Lung cancer Screening, Incidence, and Outcomes in Asian Americans (5 minute version)Подробнее

Lung cancer Meet 2023 - 04 NovПодробнее

Lung Conclave 2024 - 10 FebПодробнее

Leptomeningeal Disease in EGFR-Mutated Lung Cancer: Can We Finally Define a Standard Treatment?Подробнее

Screening pantumor mutations using high multiplexing panels for EGFR and ESR1Подробнее

SK Dharmalingam Lecture Series 32: Demystifying Lung Cancer - A Primary Care ImportanceПодробнее

Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLCПодробнее

Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management StrategiesПодробнее

Germline EGFR Mutations and Familial Lung CancerПодробнее